Related Experiment Video
Updated: Jun 29, 2025

Working with Human Tissues for Translational Cancer Research
Published on: November 26, 2015
Editorial for the Special Issue "Latest Review Papers in Molecular Oncology 2023"
1Department of Systems Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.
Abstract:
Human cancers are products of multistep processes resulting in abnormal cell growth and differentiation, along with a loss of apoptotic function, leading to the uncontrolled expansion of neoplastic cells and their spread to surrounding tissues and, ultimately, distant parts of the body [...].
Insights
Human cancers arise from multistep processes causing abnormal cell growth and loss of apoptosis. This leads to uncontrolled neoplastic cell expansion and metastasis throughout the body.
Area of Science:
- Oncology and Molecular Biology: Investigating the fundamental mechanisms of human cancer development.
Background:
- Human cancers result from complex, multistep processes.
- Key events include abnormal cell growth, differentiation, and apoptosis evasion.
- These alterations drive uncontrolled neoplastic cell proliferation and spread.
Discussion:
- The uncontrolled expansion of neoplastic cells is a hallmark of cancer.
- Loss of apoptotic function contributes significantly to tumor progression.
- Metastasis involves the spread of cancer cells to surrounding tissues and distant organs.
Key Insights:
- Cancer is a multistep disease involving genetic and cellular dysregulation.
- Apoptosis evasion is critical for tumor survival and growth.
- Understanding these processes is vital for developing effective cancer therapies.
Outlook:
- Further research into cancer's multistep nature can reveal new therapeutic targets.
- Investigating apoptosis pathways may offer strategies to combat cancer progression.
- Elucidating the mechanisms of metastasis is crucial for improving patient outcomes.
More Related Videos
07:03Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology
Published on: December 1, 2023
08:29Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
Published on: October 2, 2014
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Treatment Resistant Cancers